-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HzKjGH6G1v00UmIDueubzbQ6MSejiUwKsptflws4Eh0ZVInQzsrkZsVq4cCk4Xna A+cvm3hPOS/PVR8dgSkUDQ== 0001104659-09-021327.txt : 20090330 0001104659-09-021327.hdr.sgml : 20090330 20090330161117 ACCESSION NUMBER: 0001104659-09-021327 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20090330 DATE AS OF CHANGE: 20090330 GROUP MEMBERS: DANIEL J. DONOGHUE GROUP MEMBERS: DISCOVERY GROUP I, LLC GROUP MEMBERS: MICHAEL R. MURPHY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DRUGSTORE COM INC CENTRAL INDEX KEY: 0001086467 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 043416255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-57797 FILM NUMBER: 09714322 BUSINESS ADDRESS: STREET 1: 411 108TH AVE. NE STREET 2: SUITE 1400 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: 4253723200 MAIL ADDRESS: STREET 1: 411 108TH AVE. NE STREET 2: SUITE 1400 CITY: BELLEVUE STATE: WA ZIP: 98004 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DISCOVERY EQUITY PARTNERS, LP CENTRAL INDEX KEY: 0001258542 IRS NUMBER: 300075082 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O DISCOVERY GROUP I, LLC STREET 2: 191 N. WACKER DRIVE SUITE 1685 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-265-9600 MAIL ADDRESS: STREET 1: C/O DISCOVERY GROUP I, LLC STREET 2: 191 N. WACKER DRIVE SUITE 1685 CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: DISCOVERY EQUITY PARTNERS LP DATE OF NAME CHANGE: 20030806 SC 13D/A 1 a09-8895_1sc13da.htm SC 13D/A

	UNITED STATES	OMB APPROVAL
	SECURITIES AND EXCHANGE COMMISSION	OMB Number: 3235-0145
	Washington, D.C. 20549
		Expires: February 28, 2009
	SCHEDULE 13D	Estimated average burden hours per response. . 14.5
	Under the Securities Exchange Act of 1934 (Amendment No. 1)*

drugstore.com, inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

262241102

(CUSIP Number)

Michael R. Murphy

Discovery Group I, LLC

191 North Wacker Drive

Suite 1685

Chicago, Illinois 60606

Telephone Number: (312) 265-9600

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

June 23, 2008

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 262241102

	1.	Names of Reporting Persons. Discovery Equity Partners, L.P.

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)			o
		(b)			o

	3.	SEC Use Only

	4.	Source of Funds (See Instructions) WC

	5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

	6.	Citizenship or Place of Organization Illinois

Number of Shares Beneficially Owned by Each Reporting Person With			7.	Sole Voting Power None.

			8.	Shared Voting Power 6,224,631

			9.	Sole Dispositive Power None.

			10.	Shared Dispositive Power 6,224,631

	11.	Aggregate Amount Beneficially Owned by Each Reporting Person 6,224,631

	12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o

	13.	Percent of Class Represented by Amount in Row (11) 6.3%

	14.	Type of Reporting Person (See Instructions) PN

CUSIP No. 262241102

	1.	Names of Reporting Persons. Discovery Group I, LLC

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)			o
		(b)			o

	3.	SEC Use Only

	4.	Source of Funds (See Instructions) AF

	5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

	6.	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With			7.	Sole Voting Power None.

			8.	Shared Voting Power 7,251,265

			9.	Sole Dispositive Power None.

			10.	Shared Dispositive Power 7,251,265

	11.	Aggregate Amount Beneficially Owned by Each Reporting Person 7,251,265

	12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o

	13.	Percent of Class Represented by Amount in Row (11) 7.3%

	14.	Type of Reporting Person (See Instructions) OO

CUSIP No. 262241102

	1.	Names of Reporting Persons. Daniel J. Donoghue

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)			o
		(b)			o

	3.	SEC Use Only

	4.	Source of Funds (See Instructions) AF

	5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

	6.	Citizenship or Place of Organization United States of America

Number of Shares Beneficially Owned by Each Reporting Person With			7.	Sole Voting Power None.

			8.	Shared Voting Power 7,251,265

			9.	Sole Dispositive Power None.

			10.	Shared Dispositive Power 7,251,265

	11.	Aggregate Amount Beneficially Owned by Each Reporting Person 7,251,265

	12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o

	13.	Percent of Class Represented by Amount in Row (11) 7.3%

	14.	Type of Reporting Person (See Instructions) IN

CUSIP No. 262241102

	1.	Names of Reporting Persons. Michael R. Murphy

	2.	Check the Appropriate Box if a Member of a Group (See Instructions)
		(a)			o
		(b)			o

	3.	SEC Use Only

	4.	Source of Funds (See Instructions) AF

	5.	Check if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o

	6.	Citizenship or Place of Organization United States of America

Number of Shares Beneficially Owned by Each Reporting Person With			7.	Sole Voting Power None.

			8.	Shared Voting Power 7,251,265

			9.	Sole Dispositive Power None.

			10.	Shared Dispositive Power 7,251,265

	11.	Aggregate Amount Beneficially Owned by Each Reporting Person 7,251,265

	12.	Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o

	13.	Percent of Class Represented by Amount in Row (11) 7.3%

	14.	Type of Reporting Person (See Instructions) IN

Item 1.	Security and Issuer
	This Amendment No. 1 to Schedule 13D (“Amendment No. 1”) relates to the Common Stock, $0.0001 par value per share (the “Common Stock”), of drugstore.com, inc., a Delaware corporation (the “Company”), which has its principal executive offices at 411 108th Avenue NE, Suite 1400, Bellevue, WA 98004. This Amendment No. 1 amends and supplements, as set forth below, the information contained in items 1, 2, 3, 5 and 6 of the Schedule 13D filed by the Reporting Persons with respect to the Company on February 19, 2008 (as so amended, the “Schedule 13D”). All capitalized terms used herein but not defined herein have the meanings set forth in the Schedule 13D. Except as amended by this Amendment No. 1, all information contained in the Schedule 13D is, after reasonable inquiry and to the best of the Reporting Persons’ knowledge and belief, true, complete and correct as of the date of this Amendment No. 1.

Item 2.	Identity and Background
	Item 2 of the Schedule 13D is hereby amended by adding the following as the second line thereof: Discovery Equity Partners, L.P. (“Discovery Equity Partners”) is an Illinois limited partnership primarily engaged in the business of investing in securities.

Item 3.	Source and Amount of Funds or Other Consideration
	Item 3 of the Schedule 13D is hereby amended to read in its entirety as follows: The total purchase price for the 7,251,265 shares of Common Stock beneficially owned by Discovery Group and Messrs. Donoghue and Murphy as of March 27, 2009 was approximately $19,033,465, and the total purchase price for the 6,224,631 shares of Common Stock beneficially owned by Discovery Equity Partners was approximately $16,338,723. The source of such funds was the assets of Discovery Equity Partners and another private investment partnership (collectively, the “Partnerships”) over which Discovery Group exercises discretionary investment management authority, including proceeds of margin loans under margin loan facilities maintained in the ordinary course of business by the Partnerships with a broker on customary terms and conditions. The Partnerships are the legal owner of all of the Common Stock beneficially owned by Discovery Group and Messrs. Donoghue and Murphy.

Item 5.	Interest in Securities of the Issuer
	Item 5 of the Schedule 13D is hereby amended to read in its entirety as follows: The information concerning percentages of ownership set forth below is based on 99,531,469 shares of Common Stock reported outstanding as of March 5, 2009 in the Company’s most recent Annual Report on Form 10-K, for the period ended December 28, 2008. Discovery Equity Partners beneficially owns 6,224,631 shares of Common Stock as of March 27, 2009, which represents 6.3% of the outstanding Common Stock. Discovery Group beneficially owns 7,251,265 shares of Common Stock as of March 27, 2009, which represents 7.3% of the outstanding Common Stock. Mr. Donoghue beneficially owns 7,251,265 shares of Common Stock as of March 27, 2009, which

	represents 7.3% of the outstanding Common Stock. Mr. Murphy beneficially owns 7,251,265 shares of Common Stock as of March 27, 2009, which represents 7.3% of the outstanding Common Stock. Discovery Group is the sole general partner of one of the Partnerships and has sole discretionary investment authority with respect to the other Partnership’s investment in the Common Stock. Messrs. Donoghue and Murphy are the sole managing members of Discovery Group. As a consequence, Discovery Group and Messrs. Donoghue and Murphy may be deemed to share beneficial ownership of all of the shares of Common Stock owned by both of the Partnerships. The transactions in Common Stock effected by the Reporting Persons during the past 60 days are set out in Exhibit 1 hereto. No person other than the Partnerships is known to any Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any of the shares of Common Stock reported herein.

Item 6.	Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer
	Item 6 of the Schedule 13D is hereby amended to read in its entirety as follows: There are no contracts, arrangements, understandings or relationships (legal or otherwise) between or among any of the Reporting Persons and any other person with respect to any securities of the Company other than the governing documents of Discovery Group and the Partnerships, the margin loan facilities referred to under Item 3 above, the Joint Filing Agreement of the Reporting Persons with respect to the Schedule 13D that was included as an exhibit thereto, the Joint Filing Agreement of the Reporting Persons with respect to this Amendment No. 1 included as Exhibit 2 to this Amendment No. 1, and the Powers of Attorney granted by Messrs Donoghue and Murphy with respect to reports under Section 13 of the Securities Exchange Act of 1934, as amended, which Powers of Attorney are included as Exhibit 3 and Exhibit 4, respectively, to this Amendment No. 1.

Item 7.	Material to be Filed as Exhibits
	Exhibit 1: List of transactions by Reporting Persons in the Company’s Common Stock during the past 60 days. Exhibit 2: Joint Filing Agreement dated as of March 30, 2009, by and among Discovery Equity Partners; Discovery Group; Daniel J. Donoghue; and Michael R. Murphy. Exhibit 3: Power of Attorney of Daniel J. Donoghue, dated as of April 28, 2008. Exhibit 4: Power of Attorney of Michael R. Murphy, dated as of April 28, 2008.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

	March 30, 2009
	Date


	DISCOVERY GROUP I, LLC, for itself and as general partner of DISCOVERY EQUITY PARTNERS, L.P.


	By: Michael R. Murphy*
	Signature
	Michael R. Murphy, Managing Member
	Name/Title
	Daniel J. Donoghue*
	Signature
	Daniel J. Donoghue
	Name/Title
	Michael R. Murphy*
	Signature
	Michael R. Murphy
	Name/Title


	*By: /s/ Mark Buckley
	Mark Buckley
	Attorney-in-Fact for Daniel J. Donoghue Attorney-in-Fact for Michael R. Murphy

Exhibit Index

Exhibit 1	List of transactions by Reporting Persons in the Company’s Common Stock during the past 60 days.

Exhibit 2	Joint Filing Agreement dated as of March 30, 2009, by and among Discovery Equity Partners; Discovery Group; Daniel J. Donoghue; and Michael R. Murphy.

Exhibit 3	Power of Attorney of Daniel J. Donoghue, dated as of April 28, 2008.

Exhibit 4	Power of Attorney of Michael R. Murphy, dated as of April 28, 2008.

EX-1 2 a09-8895_1ex1.htm EX-1

EXHIBIT 1

TRANSACTIONS DURING THE PAST 60 DAYS

The Reporting Persons engaged in the following transactions in shares of Common Stock of the Company during the past 60 days. Such transactions involved the purchase of shares on the Nasdaq National Market System.

Date	Type	Price		Shares
1/30/2009	Purchase	$	0.90	5000
2/23/2009	Purchase	0.86		5000
2/23/2009	Purchase	0.87		2500
2/23/2009	Purchase	0.88		20000
2/23/2009	Purchase	0.90		2500
2/24/2009	Purchase	0.90		19200
2/25/2009	Purchase	0.8601		1500
2/25/2009	Purchase	0.87		1200
2/25/2009	Purchase	0.88		2000
2/25/2009	Purchase	0.89		4500
2/25/2009	Purchase	0.90		5000
2/26/2009	Purchase	0.87		881
2/26/2009	Purchase	0.88		7500
2/26/2009	Purchase	0.89		7998
2/26/2009	Purchase	0.895		200
2/26/2009	Purchase	0.8998		300
2/26/2009	Purchase	0.90		2100
2/27/2009	Purchase	0.8614		2900
2/27/2009	Purchase	0.88		10000
2/27/2009	Purchase	0.89		12500
2/27/2009	Purchase	0.90		10000
3/2/2009	Purchase	0.80		6479
3/2/2009	Purchase	0.8002		400
3/2/2009	Purchase	0.8003		2100
3/2/2009	Purchase	0.8006		6100
3/2/2009	Purchase	0.801		9000
3/2/2009	Purchase	0.8018		700
3/2/2009	Purchase	0.8024		100
3/2/2009	Purchase	0.8066		100
3/2/2009	Purchase	0.81		5100
3/2/2009	Purchase	0.8101		6617
3/2/2009	Purchase	0.8102		1200
3/2/2009	Purchase	0.8103		100
3/2/2009	Purchase	0.8105		100
3/2/2009	Purchase	0.8108		300
3/2/2009	Purchase	0.8119		800
3/2/2009	Purchase	0.8121		100
3/2/2009	Purchase	0.8125		200

Date	Type	Price		Shares
3/2/2009	Purchase	$	0.8131	100
3/2/2009	Purchase	0.8145		100
3/2/2009	Purchase	0.8148		1500
3/2/2009	Purchase	0.815		100
3/2/2009	Purchase	0.8151		100
3/3/2009	Purchase	0.74		200
3/3/2009	Purchase	0.7425		100
3/3/2009	Purchase	0.7449		100
3/3/2009	Purchase	0.75		10800
3/3/2009	Purchase	0.7525		100
3/3/2009	Purchase	0.755		1600
3/3/2009	Purchase	0.7599		944
3/3/2009	Purchase	0.76		300
3/3/2009	Purchase	0.77		5400
3/3/2009	Purchase	0.7705		100
3/3/2009	Purchase	0.7725		300
3/3/2009	Purchase	0.775		5056
3/3/2009	Purchase	0.78		5500
3/3/2009	Purchase	0.781		300
3/3/2009	Purchase	0.7825		200
3/3/2009	Purchase	0.785		333
3/3/2009	Purchase	0.7851		1495
3/3/2009	Purchase	0.7863		200
3/3/2009	Purchase	0.7876		3805
3/3/2009	Purchase	0.7888		300
3/3/2009	Purchase	0.79		3767
3/3/2009	Purchase	0.7903		1000
3/3/2009	Purchase	0.795		2500
3/3/2009	Purchase	0.80		2500
3/3/2009	Purchase	0.82		1000
3/4/2009	Purchase	0.84		800
3/4/2009	Purchase	0.8497		100
3/4/2009	Purchase	0.85		44100
3/4/2009	Purchase	0.8599		2789
3/4/2009	Purchase	0.86		7211
3/4/2009	Purchase	0.8601		200
3/5/2009	Purchase	0.7601		3529
3/5/2009	Purchase	0.77		5000
3/5/2009	Purchase	0.7701		5000
3/5/2009	Purchase	0.7726		5000
3/5/2009	Purchase	0.78		10000
3/5/2009	Purchase	0.79		200
3/5/2009	Purchase	0.7929		100
3/5/2009	Purchase	0.80		5000
3/5/2009	Purchase	0.81		5000
3/5/2009	Purchase	0.8194		100

Date	Type	Price		Shares
3/5/2009	Purchase	$	0.8195	1622
3/5/2009	Purchase	0.82		200
3/5/2009	Purchase	0.8201		10100
3/5/2009	Purchase	0.8204		100
3/5/2009	Purchase	0.8208		100
3/5/2009	Purchase	0.8216		700
3/5/2009	Purchase	0.8217		100
3/5/2009	Purchase	0.822		100
3/5/2009	Purchase	0.8226		200
3/5/2009	Purchase	0.8238		400
3/5/2009	Purchase	0.8244		100
3/5/2009	Purchase	0.8245		100
3/5/2009	Purchase	0.825		500
3/5/2009	Purchase	0.8251		100
3/5/2009	Purchase	0.8263		100
3/5/2009	Purchase	0.83		800
3/6/2009	Purchase	0.76		5439
3/6/2009	Purchase	0.7802		5000
3/6/2009	Purchase	0.80		16700
3/6/2009	Purchase	0.8001		3600
3/6/2009	Purchase	0.805		300
3/6/2009	Purchase	0.8051		9100
3/6/2009	Purchase	0.82		13540
3/6/2009	Purchase	0.84		100
3/6/2009	Purchase	0.845		100
3/6/2009	Purchase	0.85		650
3/6/2009	Purchase	0.855		667
3/6/2009	Purchase	0.8559		100
3/6/2009	Purchase	0.8575		400
3/6/2009	Purchase	0.86		10176
3/6/2009	Purchase	0.8601		256
3/6/2009	Purchase	0.865		5473
3/6/2009	Purchase	0.8651		600
3/6/2009	Purchase	0.8686		100
3/6/2009	Purchase	0.8699		300
3/6/2009	Purchase	0.87		1628
3/9/2009	Purchase	0.80		7344
3/9/2009	Purchase	0.81		5000
3/9/2009	Purchase	0.815		1000
3/9/2009	Purchase	0.82		10000
3/9/2009	Purchase	0.83		24
3/9/2009	Purchase	0.8417		200
3/9/2009	Purchase	0.8418		5076
3/10/2009	Purchase	0.84		4700
3/10/2009	Purchase	0.841		300
3/10/2009	Purchase	0.85		11200

Date	Type	Price		Shares
3/10/2009	Purchase	$	0.853	86
3/10/2009	Purchase	0.86		10300
3/10/2009	Purchase	0.8603		100
3/10/2009	Purchase	0.8605		300
3/10/2009	Purchase	0.8606		1300
3/10/2009	Purchase	0.8612		100
3/10/2009	Purchase	0.862		100
3/10/2009	Purchase	0.8623		400
3/10/2009	Purchase	0.8624		100
3/10/2009	Purchase	0.8625		100
3/10/2009	Purchase	0.8627		100
3/10/2009	Purchase	0.8636		100
3/10/2009	Purchase	0.8641		100
3/10/2009	Purchase	0.8647		500
3/10/2009	Purchase	0.865		700
3/10/2009	Purchase	0.8654		400
3/10/2009	Purchase	0.87		9722
3/10/2009	Purchase	0.88		2000
3/10/2009	Purchase	0.89		1000
3/10/2009	Purchase	0.90		1000
3/11/2009	Purchase	0.85		400
3/11/2009	Purchase	0.86		11200
3/11/2009	Purchase	0.88		48686
3/11/2009	Purchase	0.90		10000
3/12/2009	Purchase	0.84		100
3/12/2009	Purchase	0.85		2000
3/12/2009	Purchase	0.88		1200
3/12/2009	Purchase	0.90		2000

EX-2 3 a09-8895_1ex2.htm EX-2

EXHIBIT 2

JOINT FILING AGREEMENT

The undersigned hereby agree to the joint filing of Amendment No. 1 to the Schedule 13D to which this Agreement is attached.

Dated: March 30, 2009

DISCOVERY GROUP I, LLC
for itself and as general partner of
DISCOVERY EQUITY PARTNERS, L.P.


By	Michael R. Murphy*
	Michael R. Murphy
	Managing Member


Daniel J. Donoghue*
Daniel J. Donoghue


Michael R. Murphy*
Michael R. Murphy


*By:		/s/ Mark Buckley
		Mark Buckley
		Attorney-in-Fact for Daniel J. Donoghue
		Attorney-in-Fact for Michael R. Murphy

EX-3 4 a09-8895_1ex3.htm EX-3

EXHIBIT 3

POWER OF ATTORNEY

The undersigned, Daniel J. Donoghue, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 and the rules thereunder on Schedule 13D or 13G, any and all amendments to such reports, with all exhibits, and any other forms or documents as may be necessary in connection with the filing of such reports with the United States Securities and Exchange Commission and any stock exchange or similar authority, granting unto said attorney full power and authority to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete, as fully as the undersigned might or could do in person.

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and agent.

IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed this 28th day of April, 2008.

	/s/ Daniel J. Donoghue
	Daniel J. Donoghue

STATE OF ILLINOIS	)
	) SS.
COUNTY OF COOK	)

I, Kareema M. Cruz, a Notary Public in and for the County of Cook, State of Illinois, DO HEREBY CERTIFY that Daniel J. Donoghue, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he signed and delivered the said instrument as his own free and voluntary act, for the uses and purposes therein set forth.

Given under my hand and notarial seal, this 28th day of April, 2008.

	/s/ Kareema M. Cruz
	Notary Public

EX-4 5 a09-8895_1ex4.htm EX-4

EXHIBIT 4

POWER OF ATTORNEY

The undersigned, Michael R. Murphy, hereby appoints Mark Buckley his true and lawful attorney-in-fact and agent, with full power to execute and file with the United States Securities and Exchange Commission and any stock exchange or similar authority, for and on his behalf in any and all capacities, any and all reports required to be filed pursuant to Section 13 of the Securities Exchange Act of 1934 and the rules thereunder on Schedule 13D or 13G, any and all amendments to such reports, with all exhibits, and any other forms or documents as may be necessary in connection with the filing of such reports with the United States Securities and Exchange Commission and any stock exchange or similar authority, granting unto said attorney full power and authority to do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete, as fully as the undersigned might or could do in person.

This Power of Attorney shall remain in full force and effect until revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact and agent.

IN WITNESS WHEREOF the undersigned has caused this Power of Attorney to be executed this 28th day of April, 2008.

	/s/ Michael R. Murphy
	Michael R. Murphy

STATE OF ILLINOIS	)
	) SS.
COUNTY OF COOK	)

I, Kareema M. Cruz, a Notary Public in and for the County of Cook, State of Illinois, DO HEREBY CERTIFY that Michael R. Murphy, who is personally known to me to be the same person whose name is subscribed to the foregoing instrument, appeared before me this day in person and acknowledged that he signed and delivered the said instrument as his own free and voluntary act, for the uses and purposes therein set forth.

Given under my hand and notarial seal, this 28th day of April, 2008.

	/s/ Kareema M. Cruz
	Notary Public

-----END PRIVACY-ENHANCED MESSAGE-----